electroCore, Inc.
NASDAQ:ECOR

Watchlist Manager
electroCore, Inc. Logo
electroCore, Inc.
NASDAQ:ECOR
Watchlist
Price: 8.03 USD 0.25% Market Closed
Market Cap: 52.6m USD

During the last 3 months electroCore, Inc. insiders bought 48.6k USD , and have not sold any shares. The stock price has dropped by 54% over this period (open performance analysis).

The last transaction was made on Mar 17, 2025 by Errico Thomas J. (Founder and Chief Science & Strategy Officer) , who bought 48.6k USD worth of ECOR shares.

Last Transactions:
Errico Thomas J.
Founder and Chief Science & Strategy Officer
$+48.6k
Errico Thomas J.
Founder and Chief Science & Strategy Officer
$+30.6k
Gandolfo John P
Chief Executive Officer
$+6.4k
Goldstein Julie Ann
Director
$+240.6
Errico Thomas J.
Founder and Chief Science & Strategy Officer
$+1.2k
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+247.6k
Patton Thomas M
Chief Operating Officer
$+240.6
Wilber Patricia
Chief Operating Officer
$+216.6
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+8.3k
Errico Thomas J.
Founder and Chief Science & Strategy Officer
$+1.4k
Goldstein Julie Ann
Director
$+1.1k
Patton Thomas M
Chief Operating Officer
$+345.3
Moody Trevor J
Chief Financial Officer
$+708.2
Cuneo F Peter
Director
$+177
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+221.8k
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+1.7k
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+1.9k
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+116.8
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+110.2
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+2.2k
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+106.2
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+100.1
Goldberger Daniel S
Founding Scientist and Senior Advisor
$+185.2
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+550.6
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+1.1k
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+2.1k
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+1.7k
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+2.1k
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+2k
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+1.6k
Errico Joseph P
President, Chief Executive Officer, Secretary and Director of electroCore, Inc.
$+1.6k
Errico Thomas J.
Founder and Chief Science & Strategy Officer
$+1.5k
View All Transactions

During the last 3 months electroCore, Inc. insiders bought 48.6k USD , and have not sold any shares. The stock price has dropped by 54% over this period (open performance analysis).

The last transaction was made on Mar 17, 2025 by Errico Thomas J. (Founder and Chief Science & Strategy Officer) , who bought 48.6k USD worth of ECOR shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
1
48.6k USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
1
30.6k USD
9-12
months
6
255.9k USD

electroCore, Inc.
Insider Trading Chart

electroCore, Inc.
Last Insider Transactions

Global
Insiders Monitor

electroCore, Inc.
Glance View

Market Cap
52.3m USD
Industry
Health Care

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 52 full-time employees. The company went IPO on 2018-06-22. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The firm is providing gammaCore device for the treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults. gammaCore permits patients to self-administer doses of nVNS on an as-needed basis for treatment of prevent multiple types of headache pain via the vagus nerve. The gammaCore therapy is also used to treat primary headache, including migraine, cluster headache (CH), hemicrania continua and paroxysmal hemicrania (PH) and coronavirus (COVID-19).

ECOR Intrinsic Value
18.52 USD
Undervaluation 57%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top